VSTM · Healthcare · $707M
$8.05+1.64%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“이번 분기 매출은 4,010만 달러로 전 분기 1,900만 달러에서 두 배 이상 늘었지만, 제품 매출은 2,510만 달러이고 1,500만 달러는”
In the company's words · 2026 2분기 earnings call